Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Innate Pharma S.A. ADS (IPHA)

https://www.innate-pharma.com

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. It specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body's immune system to recognize and kill cancer cells. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, avdoralimab, and others.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/09/2015

Market Cap

179,414,976

Shares Outstanding

80,860,000

Weighted SO

80,841,988

Total Employees

N/A

Upcoming Earnings

03/10/2020

Beta

0.8080

Last Div

0.0000

Range

1.81-3.15

Chg

-0.0336

Avg Vol

8656

Mkt Cap

179414976

Exch

NASDAQ

Country

FR

Phone

33 4 30 30 30 30

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

1.9702

EV Multiple

-6.2672

P/FV

3.1361

Div Yield %

0.0000

P/E

-14.3343

PEG

-6.9353

Payout

0.0000

Current Ratio

3.7342

Quick Ratio

3.7342

Cash Ratio

1.7813

DSO

205.1279

DIO

0.0000

Op Cycle

205.1279

DPO

55.7775

CCC

149.3504

Gross Margin

0.3228

Op Margin

-0.3475

Pretax Margin

-0.2549

Net Margin

-0.1373

Eff Tax Rate

0.4614

ROA

-0.0616

ROE

-0.2069

ROCE

-0.1988

NI/EBT

0.5386

EBT/EBIT

0.7335

EBIT/Rev

-0.3475

Debt Ratio

0.2147

D/E

0.7619

LT Debt/Cap

0.3710

Total Debt/Cap

0.4324

Int Coverage

-15.6640

CF/Debt

-1.2350

Equity Multi

3.5489

Rec Turnover

1.7794

Pay Turnover

6.5439

Inv Turnover

999999.9999

FA Turnover

13.0847

Asset Turnover

0.4491

OCF/Share

-0.6041

FCF/Share

-0.6354

Cash/Share

1.1437

OCF/Sales

-0.5904

FCF/OCF

1.0518

CF Coverage

-1.2350

ST Coverage

-5.4652

CapEx Coverage

-19.3070

Div&CapEx Cov

-19.3070

P/BV

3.1361

P/B

3.1361

P/S

1.9702

P/E

-14.3343

P/FCF

-3.1729

P/OCF

-3.3328

P/CF

-3.3328

PEG

-6.9353

P/S

1.9702

EV Multiple

-6.2672

P/FV

3.1361

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation